Top brokers have slapped a "buy" on these two small cap stocks

Australian shares have lost a lot of value since the start of last month but it's the S&P/ASX 200 (Index:^AXJO) (ASX:XJO) and not small caps that have taken most of the beating.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

Our market can't shake the October blues with experts warning of more volatility ahead.

Australian shares have lost a lot of value since the start of last month but it's the larger cap stocks that have taken most of the beating.

This says to me that the market weakness is driven primarily from global risk factors instead of domestic issues as shares at the bigger end of town are more severely impacted by international turbulence than small cap stocks.

Small caps punching above their weight

The S&P/ASX 200 (Index:^AXJO) (ASX:XJO) index has lost nearly 9% of its value since the end of September when the S&P/ASX SMALL ORDINARIES (Index:^AXSO) (ASX: XSO) is down 7%.

That two-percentage point difference may not sound like much but it's a big deal and I think the small cap index has a better than even chance to keep outperforming their bigger brothers over the next three to six months (this is mainly because I think our big banks will struggle to perform in the short-term).

If you are looking for small cap buying opportunities, there are two stocks that have caught the eye of brokers recently.

Broker picks

The first is insurance broker AUB Group Ltd (ASX: AUB) with Credit Suisse adding the stock to its "buy" list after the AUB share price tumbled 12% over the past week.

A capital raising and worries about new regulations on the insurance industry have weighed on the stock but Credit Suisse thinks the stock will come bouncing back.

"There are current concerns around ASIC's comments in their recent Royal Commission submission on the topic of banning general insurance comments," said the broker.

"[But] the vast majority of an insurance brokers business is not in relation to retail products."

Credit Suisse also believes that earnings growth is also starting to pick up again after slowing to around 5% a year in the last five years as AUB diversified its business.

But AUB posted growth of 6.2% in FY17 and 10.3% in FY18 as these investments rolled-off, and the broker believes this trend will persist.

Credit Suisse has a $14.50 price target on the stock.

The second small cap to watch is  aerial mapping technology company Nearmap Ltd (ASX: NEA). The NEA share price is surging 7.4% in later afternoon trade to $1.60 in the wake of its annual general meeting (AGM).

Management said it's off to a strong start in the first quarter of FY19 and confirmed that it will be cashflow breakeven by this financial year.

Morgan Stanley reiterated its "overweight" recommendation on the stock following the AGM with a $2 per share price target on the stock.

Motley Fool contributor Brendon Lau has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Nearmap Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Magellan and Ramsay Health Care shares

A leading expert forecasts growing headwinds for Magellan and Ramsay Health Care shares. But why?

Read more »

A beautiful ocean vista is shown with a woman whose back is to the camera holding her arms up in triumph as she stands at the top of a rock feeling thrilled that ASX 200 shares are reaching multi-year high prices today
ASX Share Market News

Record breaker! The ASX 200 just hit a fresh all-time high

Investors just sent the ASX 200 into uncharted territory.

Read more »

Pilot on the phone looking distraught.
Broker Notes

Sell alert! Why this expert is ditching Qantas shares for this ASX 200 defence stock

A leading expert is selling Qantas shares and buying this surging ASX 200 defence stock instead. But why?

Read more »

An old-fashioned news boy stands on a stool and yells through a microphone in an open field.
ASX Share Market News

Why is everyone talking about Domino's, Light & Wonder and BHP shares on Wednesday?

BHP, Light & Wonder, and Domino’s shares are turning heads today. But why?

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

Up 64%, 3 reasons this expert predicts Pro Medicus shares will keep on giving

A leading expert forecasts more outperformance from the surging Pro Medicus share price.

Read more »

A woman leans forward with her hand behind her ear, as if trying to hear information.
ASX Share Market News

Earnings preview: can Cochlear shares rebound?

A decade low share price meets a make-or-break result.

Read more »

Business man marking buy on board and underlining it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Brokers believe that now could be the time to buy these shares.

Read more »

A scientist in a white coat and glasses puts her arms in the air in a sign of strength and success.
Broker Notes

Morgans tips a 600%+ return for this ASX biotech stock

Good clinical study progress has the broker bullish on this company.

Read more »